Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in RPRX — Royalty Pharma plc

CIK 1009207 New York, NY
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$29,443,141
-$24,381,452 QoQ
Shares Held
525,114
-53.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#88
of 646 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. RPRX ranks #39 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in RPRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,443,141 525,114
2026-03-31 $53,824,593 1,122,047
2025-12-31 $32,404,005 838,613
2025-09-30 $4,940,187 140,028
2025-06-30 $1,217,669 33,796
2025-03-31 $8,586,868 275,839
2024-12-31 $29,624,865 1,161,304
2024-09-30 $26,375,898 932,340
2024-06-30 $886,348 33,612
2023-12-31 $376,040 13,387
2023-09-30 $10,797,540 397,846
2023-06-30 $13,113,745 426,602
2023-03-31 $11,883,413 329,820
2022-12-31 $25,321,411 640,724
2022-09-30 $27,394,161 681,786
2022-06-30 $6,358,465 151,248
2022-03-31 $3,167,486 81,301
2021-06-30 $2,217,354 54,095